NCT05846971 2023-05-06Clinical Utility of Methylation-based Prognostic Assay for Barrett's EsophagusCapsulomics, Inc.Phase NA Unknown100 enrolled
NCT01905202 2014-08-04The Safety and Tolerability of Secretrol in Patients With Barrett's EsophagusEffexus PharmaceuticalPhase 1 Unknown13 enrolled